Drug
satralizumab
Marketed as ENSPRYNG.
Generic name
satralizumab
Brand names
ENSPRYNG
First FDA approval
2020-08-14
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761149 | ENSPRYNG | 2020-08-14 | GENENTECH |
Manufacturers
GENENTECH
Frequently asked questions
When was satralizumab FDA approved?
Earliest FDA approval on record: 2020-08-14.
What brand names are sold as satralizumab?
ENSPRYNG.
Sources
Appeal a satralizumab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com